Top Broker Regulation Stories
Forest Labs profit drops on Lexapro competition
By Associated PressForest Laboratories Inc. said Tuesday its net income dropped 79 percent in the fiscal first quarter after its antidepressant Lexapro lost patent protection, allowing other companies to sell low-cost versions of the drug.
